On October 10, 2018 Janssen Pharmaceuticals of Johnson & Johnson reported tha it will present new data from the entire cancer portfolio at the 2018 annual European Society for Medical Oncology (ESMO) (Free ESMO Whitepaper) congress, which will be held from 19 to 23 October in Munich, Germany (Press release, Johnson & Johnson, OCT 10, 2018, View Source [SID1234529848]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The original text of this announcement, written in the source language, is the official version that is authentic. Translations are offered solely for the convenience of the reader and must refer to the original text, which is the only legally valid one.